In the face of rising costs, food insecurity, and healthcare inequality, the Compassion Center's Coalition for Patient Rights is bringing Las Vegas together for a family-friendly day of food, spirits, music, toy donations, empowerment and community care. With support from our local sponsors, bring a new toy to the charity hoedown for a free raffle ticket and the chance to join in on a good cause. The Compassion Center invites the public to eat, drink, dance, and connect- raising funds and awareness for patient rights, veteran support, and vital local programs for all those who need them.
Read MoreMr. Morgret, a German speaker, has been working with TRNR since September, with a sole focus on the audit and financial workflows required to complete the acquisition of Sportstech
Mr. Morgret is based in Europe, the region that will generate substantially all of TRNR's expected 2025 pro forma revenue of more than $80M, and will transition to CFO on November 15
Michael Madigan, TRNR's current CFO, to step down after Q3 earnings on November 14, having taken the company public and guided it through two significant acquisitions
Read MoreGorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime
Read More
The Compassion Center and its Coalition for Patient Rights (CPR) tap Las Vegas mainstay Lex LasVegas to host a family-friendly day of music, advocacy, and community well-being on Saturday, November 15, 2025, 10 a.m.-6 p.m., at 4775 McLeod Dr., Las Vegas, NV 89121. In the lead-up, fans are invited to The Official 4Horsemen of Comedy Costume Party & Legendary 4Horseman Khalil Mack's Birthday on Wednesday, October 29, 2025, 9 p.m.-1 a.m.++ at Hola Habibi, with Blaque Tacos and a prize for Best Outfit.
Read More
Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition.
Read MoreIcotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement versus placebo
Updated ANTHEM-UC data support Phase 3 clinical development of icotrokinra in both moderately to severely active ulcerative colitis and Crohn's disease
In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ICONIC-TOTAL study
Further, 67% of patients treated with icotrokinra in the ICONIC-TOTAL study achieved overall rates of clear or almost clear skin by Week 24, which was maintained through Week 52
Read MoreAdvancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration
Read More
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
Read MoreNew findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.
Read More
OI Suite Discovery Program launches with complimentary access for researchers in biopharma companies and academic centers to accelerate biomarker discovery through an intuitive, no-code interface.
CanvOI, running on Oracle Cloud Infrastructure (OCI), is now trained on more than 1.5 million biopsy images across 40+ organs and designed to perform in small early-phase cohorts.
Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, quantum technology, semiconductors, mobility, and solar panel recycling solution.
Read More